marginally significantP = 0.082
Classification based on the underlying airway disease showed an increased AI risk in patients with asthma (HR: 3.10, 95% CI: 1.84–5.23) and a marginally significant risk in patients with COPD (HR: 3.23, 95% CI: 0.86–12.16, P = 0.082).